Center-Authored Papers

Filters: Author is Edlefsen, Paul T  [Clear All Filters]
Journal Article
Gartland AJ, Li S, McNevin J, Tomaras GD, Gottardo R, Janes H, Fong Y, Morris D, Geraghty DE, Kijak GH et al..  2014.  Analysis of HLAA*02 association with vaccine efficacy in the RV144 HIV-1 vaccine trial.. Journal of virology. Abstract
Fukazawa Y, Lum R, Okoye AA, Park H, Matsuda K, Bae JY, Hagen SI, Shoemaker R, Deleage C, Lucero C et al..  2015.  B cell follicle sanctuary permits persistent productive simian immunodeficiency virus infection in elite controllers.. Nature medicine. 21(2):132-9. Abstract
Dommaraju K, Kijak G, Carlson JM, Larsen BB, Tovanabutra S, Geraghty DE, Deng W, Maust BS, Edlefsen PT, Sanders-Buell E et al..  2014.  CD8 and CD4 epitope predictions in RV144: no strong evidence of a T-cell driven sieve effect in HIV-1 breakthrough sequences from trial participants.. PloS one. 9(10):e111334. Abstract
Edlefsen PT, Rolland M, Hertz T, Tovanabutra S, Gartland AJ, Decamp AC, Magaret CA, Ahmed H, Gottardo R, Juraska M et al..  2015.  Comprehensive sieve analysis of breakthrough HIV-1 sequences in the RV144 vaccine efficacy trial.. PLoS computational biology. 11(2):e1003973. Abstract
Hansen SG, Sacha JB, Hughes CM, Ford JC, Burwitz BJ, Scholz I, Gilbride RM, Lewis MS, Gilliam AN, Ventura AB et al..  2013.  Cytomegalovirus vectors violate CD8+ T cell epitope recognition paradigms.. Science (New York, N.Y.). 340(6135):1237874. Abstract
Edlefsen PT, Liu C, Dempster AP.  2009.  Estimating limits from Poisson counting data using Dempster-Shafer analysis.. The Annals of Applied Statistics. 3(2):764-790.
Kolker E, Picone AF, Galperin MY, Romine MF, Higdon R, Makarova KS, Kolker N, Anderson GA, Qiu X, Auberry KJ et al..  2005.  Global profiling of Shewanella oneidensis MR-1: expression of hypothetical genes and improved functional annotations.. Proceedings of the National Academy of Sciences of the United States of America. 102(6):2099-104. Abstract
Hansen SG, Piatak M, Ventura AB, Hughes CM, Gilbride RM, Ford JC, Oswald K, Shoemaker R, Li Y, Lewis MS et al..  2013.  Immune clearance of highly pathogenic SIV infection.. Nature. 502(7469):100-4. Abstract
Rolland M, Edlefsen PT, Larsen BB, Tovanabutra S, Sanders-Buell E, Hertz T, Decamp AC, Carrico C, Menis S, Magaret CA et al..  2012.  Increased HIV-1 vaccine efficacy against viruses with genetic signatures in Env V2.. Nature. 490(7420):417-20. Abstract
Edlefsen PT.  2014.  Leaky vaccines protect highly exposed recipients at a lower rate: implications for vaccine efficacy estimation and sieve analysis.. Computational and mathematical methods in medicine. 2014:813789. Abstract
Sterrett S, Learn GH, Edlefsen PT, Haynes BF, Hahn BH, Shaw GM, Bar KJ.  2014.  Low Multiplicity of HIV-1 Infection and No Vaccine Enhancement in VAX003 Injection Drug Users.. Open forum infectious diseases. 1(2):ofu056. Abstract
Fukazawa Y, Park H, Cameron MJ, Lefebvre F, Lum R, Coombes N, Mahyari E, Hagen SI, Bae JY, Iii MDR et al..  2012.  Lymph node T cell responses predict the efficacy of live attenuated SIV vaccines.. Nature medicine. 18(11):1673-81. Abstract
Edlefsen PT, Birkmann A, Huang M-L, Magaret CA, Kee JJ, Diem K, Goldner T, Timmler B, Stoelben S, Ruebsamen-Schaeff H et al..  2016.  No Evidence of Pritelivir Resistance Among Herpes Simplex Virus Type 2 Isolates After 4 Weeks of Daily Therapy.. The Journal of infectious diseases. 214(2):258-264. Abstract
Wagner TA, McLaughlin S, Garg K, Cheung CYK, Larsen BB, Styrchak S, Huang HC, Edlefsen PT, Mullins JI, Frenkel LM.  2014.  Proliferation of cells with HIV integrated into cancer genes contributes to persistent infection.. Science (New York, N.Y.). Abstract
Edlefsen PT, Gilbert PB, Rolland M.  2013.  Sieve analysis in HIV-1 vaccine efficacy trials.. Current opinion in HIV and AIDS. Abstract
Fiore-Gartland A, Kullman N, Decamp AC, Clenaghan G, Yang W, Magaret CA, Edlefsen PT, Gilbert PB.  2017.  SieveSifter: a web-based tool for visualizing the sieve analyses of HIV-1 vaccine efficacy trials.. Bioinformatics (Oxford, England). 33(15):2386-2388. Abstract
Edlefsen PT, Liu JS.  2010.  Transposon identification using profile HMMs.. BMC genomics. 11 Suppl 1:S10. Abstract
Huang Y, Karuna ST, Janes H, Frahm N, Nason M, Edlefsen PT, Kublin JG, Corey L, McElrath MJ, Gilbert PB.  2015.  Use of placebos in Phase 1 preventive HIV vaccine clinical trials.. Vaccine. 33(6):749-52. Abstract
Zolla-Pazner S, Edlefsen PT, Rolland M, Kong X-P, DeCamp A, Gottardo R, Williams C, Tovanabutra S, Sharpe-Cohen S, Mullins JI et al..  2014.  Vaccine-induced Human Antibodies Specific for the Third Variable Region of HIV-1 gp120 Impose Immune Pressure on Infecting Viruses.. EBioMedicine. 1(1):37-45. Abstract